Vaxart, Inc. appointed Raquel C. Bono, M.D., a retired U.S. Navy Vice Admiral and former Director of the Defense Health Agency, to its Board of Directors effective October 16, 2026. Dr. Bono will serve as Chair of the Stockholder Engagement Committee and was appointed pursuant to a cooperation agreement entered into with a group of stockholders in July 2026.
Paula Dempsey resigned as Chief Financial Officer of Torrid Holdings Inc. effective November 12, 2026, to pursue another opportunity. The company appointed Will Langley, former CFO of Belk, Inc., as Interim Chief Financial Officer effective October 28, 2026, with an annual base salary of $702,000.
Alexandra Peterson and Gabrielle Toledano resigned from the Board of Directors of Polomar Health Services, Inc., effective October 14, 2026. Following these departures, the Board reduced its size from five to three directors. The company stated the resignations were not due to any disagreements regarding operations, policies, or practices.
Tempest Therapeutics appointed Mr. John Frederick as a Class III director to its Board of Directors, effective October 13, 2026. Mr. Frederick, a former CFO of Skillsoft Corp., will receive an initial option award to purchase 25,000 shares of common stock as part of his compensation under the company's non-employee director policy. The appointment is intended to strengthen the company's financial and capital markets expertise as it advances its in vivo CAR-T therapy pipeline.
American Clean Resources Group terminated Luke McPherson as CFO and appointed Anthony Evers as Fractional CFO, Principal Financial Officer, and Principal Accounting Officer. Mr. Evers will provide services through a consulting agreement with Satevers II LLC at an initial rate of $250 per hour, increasing to $275 after 90 days.
Elventix Technology Corp appointed Fernando Martins Jose Maria to its Board of Directors, effective October 19, 2026. Mr. Martins Jose Maria previously served as Lead Software Architect at Softplan and is an independent technical consultant. He will serve until the next annual meeting of stockholders or until a successor is elected.
NRC Health has appointed its current CEO, Trent Green, to the additional role of interim principal financial officer effective October 14, 2026. No compensation changes were made in connection with this appointment, and Mr. Green has served as the company's CEO since June 2025.
Williams-Sonoma, Inc. appointed Lynn Martin, the current President of NYSE Group, to its Board of Directors effective October 19, 2026. Ms. Martin will receive standard pro-rated non-employee director compensation and brings extensive expertise in technology, data, and capital markets to the board.
BNB Standard Corporation appointed Alex Odagiu as Chief Executive Officer, effective October 19, 2026, following his service as Interim President. William B. Miller, who served as Interim Principal Executive Officer, will continue in his roles as Chief Financial Officer and principal accounting officer.
Tamboran Resources appointed its current CEO, Todd Abbott, to the additional role of Managing Director and as a Class II director on the Board. The appointment formalizes his executive leadership at the board level as the company transitions from the appraisal phase to the development of its Beetaloo Basin assets. Mr. Abbott will not receive additional compensation for his service as a director.
Gary S. Maier and John M. Palumbo resigned as directors of Omnitek Engineering Corp. effective October 15, 2026. The company stated the resignations were not due to any disagreements regarding operations, policies, or practices.
Sean Dollinger has resigned as CEO and from the board of LQR House Inc., effective October 16, 2026, as the company pivots toward its New Zealand-based securities brokerage business. Leo Chen, former Chairman of Shenzhen Jincheng Confidentiality Technology, has been appointed as the new CEO. As part of a separation agreement, Dollinger will receive a $500,000 cash payment and the company will divest its online spirits business (LQR House Acquisition Corp.) to an entity designated by Dollinger.
Scott Greenberg resigned as a member of the Board of Directors and all committees of OpenWorld, Inc., effective October 15, 2026. The company also received shareholder approval via written consent to amend its articles of incorporation to authorize 500 million shares of a new 'blockchain common stock' class.
Olivia M. Caley resigned as interim Principal Financial Officer and Principal Accounting Officer effective October 13, 2026. In response, the board designated CEO Jeffrey Newgard as interim Principal Financial Officer and Controller Christine Nelson as interim Principal Accounting Officer while searching for a permanent CFO.
Teresa DeLuca, M.D., notified the Board of Directors of LifeStance Health Group, Inc. of her resignation from the Board and all committees, effective December 31, 2026. The company stated the resignation was not due to any disagreement with the company.
Farmhouse, Inc. appointed Kevin Asher as Chief Financial Officer, effective October 12, 2026, succeeding Lanny R. Lang who voluntarily resigned from the role. Mr. Lang will remain with the company in a non-officer capacity as Senior Director of Financial Reporting to lead the financial reporting process. Mr. Asher, who previously served as the company's CFO until 2021, will receive a monthly cash fee of $2,000 and a restricted stock award of 170,000 shares.
Mary Szela resigned from the Board of Directors and its committees effective October 16, 2026, with no reported disagreements. To fill the resulting vacancies, the Board appointed Graeme Bell as chairperson of the Compensation Committee and Akiko Moni Miyashita as a member of the Audit Committee.
Feel The World, Inc. (dba XERO Shoes) appointed Zachary Guzy as Chief Financial Officer, effective October 16, 2026. He succeeds Heidi Huntington, who resigned to pursue other professional opportunities. Mr. Guzy will receive an annual base salary of $290,000 and is eligible for the company's annual bonus and equity compensation plans.
Derek L. Tyus has resigned from the Boards of Directors of Waterstone Financial, Inc. and WaterStone Bank, effective October 20, 2026. Mr. Tyus is stepping down to pursue a new professional commitment, and his departure is not due to any disagreement with the company's operations or policies.
Stephen Bardin, the Chief Financial Officer, principal accounting officer, and principal financial officer of CalciMedica, Inc., has resigned to pursue another professional opportunity. The resignation is effective immediately following the filing of the company's Quarterly Report on Form 10-Q for the period ended September 30, 2026, and was not due to any disagreement with the company.
Garry Nicholson and Gabriela Gruia, M.D., resigned from the Board of Directors of TScan Therapeutics effective October 13, 2026. The company stated the resignations were not due to any disagreements and announced the appointment of Stephen Biggar and R. Keith Woods to the Nominating and Corporate Governance Committee to fill the vacancies.
Post Holdings announced that Senior VP and Chief Accounting Officer Bradly A. Harper is taking a temporary medical leave of absence. Matthew J. Mainer, the company's current CFO, will serve as Interim Chief Accounting Officer and principal accounting officer during this period.
Mobia Medical, Inc. appointed Myriam J. Curet, M.D., to its nominating and corporate governance committee, effective October 15, 2026. This filing is an amendment to a previous 8-K to finalize her committee assignment following her earlier election to the Board of Directors.
Mobia Medical, Inc. announced that the Board of Directors appointed Dr. Reza Zadno to its audit committee, effective October 15, 2026. Dr. Zadno, who was previously elected to the Board, will also continue to serve on the company's compensation committee.
Bank of Marin Bancorp announced that Brandi Campbell, Executive Vice President and Head of Retail Banking, has mutually agreed to terminate her employment effective October 16, 2026. Under a separation agreement, she will receive three months of lump-sum pay and nine months of COBRA premium reimbursements in exchange for a release of claims.
Sanjay Nayak, M.B.B.S., Ph.D., notified Ocular Therapeutix of his resignation as Chief Strategy Officer, effective October 16, 2026. Dr. Nayak is leaving the company to become the Chief Executive Officer of a privately-held company.
Quantum Cyber N.V. appointed Major General (Retired) Alberto C. Rosende to its Board of Directors, effective October 12, 2026. Maj. Gen. Rosende, who currently serves as CEO of M2i Global Inc., will also serve on the Audit, Compensation, and Nomination Committees. He brings nearly 40 years of U.S. Army command experience to the board and will receive the company's standard non-employee director compensation.
Michael C. Dennison is stepping down as CEO and resigning from the Board of Directors effective October 15, 2026. Independent director Douglas J. Grimm has been appointed Interim CEO while the Board initiates a search for a permanent successor. The transition occurs as the company reports preliminary Q3 results below expectations and updates its fiscal 2026 outlook.
AT&T Inc. filed an 8-K under Item 5.02 reporting a change in its leadership structure or board composition effective October 14, 2026. While the specific names and roles are detailed in the full filing exhibits, the disclosure triggers the requirement for reporting the appointment or departure of directors or certain senior officers.
Robert George has resigned as Chief Financial Officer of WidePoint Corporation, effective upon the filing of the company's Q3 2026 Form 10-Q. The resignation is for personal and family reasons and not due to any disagreement with the company. Mr. George will remain with the company in a non-officer capacity to assist with the transition of his responsibilities.